Gushengtang Holdings Ltd
HKEX:2273
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
33.25
51.35
|
Price Target |
|
We'll email you a reminder when the closing price reaches HKD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Gushengtang Holdings Ltd
Gross Profit
Gushengtang Holdings Ltd
Gross Profit Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Gross Profit | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
G
|
Gushengtang Holdings Ltd
HKEX:2273
|
Gross Profit
ÂĄ700m
|
CAGR 3-Years
17%
|
CAGR 5-Years
19%
|
CAGR 10-Years
N/A
|
|
Guangzhou Kingmed Diagnostics Group Co Ltd
SSE:603882
|
Gross Profit
ÂĄ2.7B
|
CAGR 3-Years
-19%
|
CAGR 5-Years
6%
|
CAGR 10-Years
N/A
|
||
Topchoice Medical Co Inc
SSE:600763
|
Gross Profit
ÂĄ1.1B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
6%
|
CAGR 10-Years
17%
|
||
Nanjing Xinjiekou Department Store Co Ltd
SSE:600682
|
Gross Profit
ÂĄ3B
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
15%
|
||
Dian Diagnostics Group Co Ltd
SZSE:300244
|
Gross Profit
ÂĄ3.4B
|
CAGR 3-Years
-11%
|
CAGR 5-Years
5%
|
CAGR 10-Years
22%
|
||
Meinian Onehealth Healthcare Holdings Co Ltd
SZSE:002044
|
Gross Profit
ÂĄ4.5B
|
CAGR 3-Years
6%
|
CAGR 5-Years
4%
|
CAGR 10-Years
33%
|
Gushengtang Holdings Ltd
Glance View
Gushengtang Holdings Ltd. operates the neo-TCM primary care platform, which combines inviting in-person care and seamless digital health powered by internet and AI technologies. The company is headquartered in Guangzhou, Guangdong. The company went IPO on 2021-12-10. The firm operates in two segments. Medical and Health Solutions segment is engaged in providing customers with traditional Chinese medical and health services through offline medical institutions and online medical and health platforms, including consultation, diagnosis, prescription services, decoctions and physical therapy. Sales of Medical and Health Products segment is mainly responsible for the sales of related products. The firm's main products include Ejiao, Cordyceps, cubilose, dendrobium, American Ginseng and other medicinal materials. The firm also provides honey, Ejiao cake and other nutritional products.
See Also
What is Gushengtang Holdings Ltd's Gross Profit?
Gross Profit
700m
CNY
Based on the financial report for Dec 31, 2023, Gushengtang Holdings Ltd's Gross Profit amounts to 700m CNY.
What is Gushengtang Holdings Ltd's Gross Profit growth rate?
Gross Profit CAGR 5Y
19%
Over the last year, the Gross Profit growth was 40%. The average annual Gross Profit growth rates for Gushengtang Holdings Ltd have been 17% over the past three years , 19% over the past five years .